Clinical Trials Browser

NCT07218003 2026-03-23

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

PETCVOCC

Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening

Primary HPV Self-Collection in Indonesia

Late Side-effects After Cervical Cancer Treatment - Prevention and Treatment

Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients

IMPROVE

JANUS

ECCO

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia

Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening

A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention

CNCMT

Effect of Nurse Navigation Program on Cervical Cancer Screening Behaviour of the Women Aged 30-65

ACCESS